HARROW, INC. — Director's Dealing 2015

May 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2015-05-18

Reporting Person: Miloni Donald Paul (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-18	Common Stock	S	300000	$8.00	Disposed	578576	Direct
2015-05-19	Common Stock	S	110000	$8.0018	Disposed	468576	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25316	Indirect
Common Stock	151898	Indirect
Common Stock	101265	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.